Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gritstone Oncology
Gritstone Oncology
Gilead partners with a cancer biotech, seeking to develop an HIV immunotherapy
BioPharma Dive
Mon, 02/1/21 - 10:48 am
Gilead Sciences
HIV
Gritstone Oncology
drug development
Gritstone posts 'one of the most potent immunogenic-responses for a neoantigen vaccine'
Fierce Biotech
Fri, 12/13/19 - 09:19 pm
Gritstone Oncology
solid tumors
vaccines
neoantigens
Gritstone Oncology Files for $102 Million Offering
CP Wire
Tue, 04/23/19 - 09:50 am
Gritstone Oncology
GRANITE-001
colorectal cancer
Gritstone Oncology Files for $102 Million Offering
Tue, 04/23/19 - 09:45 am
Gritstone Oncology
GRANITE-001
colorectal cancer
Immuno-Oncology Players Gritstone And Sutro Join The Biotech IPO Frenzy
Forbes
Wed, 09/19/18 - 11:31 am
biotech
IPOs
immuno-oncology
Gritstone Oncology
Sutro BioPharma
Bluebird taps Gritstone for oncology cell therapy targets
Fierce Biotech
Thu, 08/23/18 - 11:04 am
Bluebird Bio
Gritstone Oncology
oncology
T-cell receptors
drug development
Bristol-Myers Squibb and Gritstone Oncology Announce Collaboration to Evaluate Novel Immunotherapy Approach in Advanced Solid Tumors
CP Wire
Thu, 07/19/18 - 10:05 am
Bristol-Myers Squibb
Gritstone Oncology
Opdivo
Yervoy
GRANITE-001
cancer
Bristol-Myers Squibb and Gritstone Oncology Announce Collaboration to Evaluate Novel Immunotherapy Approach in Advanced Solid Tumors
Thu, 07/19/18 - 09:46 am
Bristol-Myers Squibb
Gritstone Oncology
Opdivo
3 Ways AI Is Changing Medicine
Motley Fool
Thu, 09/21/17 - 08:30 am
artificial intelligence
Gritstone Oncology
Alphabet
cancer immunotherapy
IBM Watson
Pfizer
Google Brain
diabetes
retinal blindness
HeartFlow
Verily
Google invests in oncology for the first time
GoInPharma
Sun, 09/10/17 - 11:50 am
Google
Alphabet
Gritstone Oncology
Going After Customized Lung Cancer Vaccines, Gritstone Grabs $102M
Forbes
Tue, 10/20/15 - 06:05 pm
vaccines
Gritstone Oncology
lung cancer
cancer immunotherapy